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ABSTRACT 
Partha Sarathi Nagchowdhuri. CONSEQUENCES OF REDUCED VERSICAN EXPRESSION IN 
EMBRYONIC CHICK SYNOVIAL JOINT DEVELOPMENT. (Under the supervision of Dr. 
Anthony A. Capehart). Department of Biology. April 2011.  
The different mechanisms involved in vertebrate synovial joint development are actively 
being uncovered.  A variety of studies have thus far discovered the involvement of several large 
molecules in the processes of joint development and cavitation. Such molecules include 
glycosaminoglycans, glycoproteins, proteoglycans, growth factors, and adhesive molecules. The 
coordinated spatiotemporal expressions of these molecules, among them chondroitin-sulfate 
proteoglycans (CSPG), are believed to play a crucial role in synovial joint formation. A previous 
study has shown that isoforms of the CSPG versican are abundantly expressed in the developing 
chick synovial joint during progressive stages of embryonic development (Shepard et al. 2007). 
The purpose of this study is to better understand the importance of versican in the developing 
limb joints by inhibiting its expression.  We employed adenoviral-mediated RNA interference 
and inovo microinjection techniques to knock down endogenous versican protein levels. Results 
show an average reduction of 14% in the non-chondrogenic space of the joint interzone of day 10 
embryos in response to versican knockdown that was coupled with attenuated expressions of key 
versican associating molecules such as hyaluronan, tenascin, CD44 and link protein. Impacts of 
versican knockdown also resulted in lowered collagen II expression among articular 
chondrocytes implying possible delays in chondrogenesis, or early transition toward an 
osteogenic fate.  
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Consequences of Reduced Versican Expression in Embryonic Chick Synovial Joint         
Development 
 
Development of the Vertebrate Limb and Synovial Joints 
 
 The tetrapod limb has served as an excellent model for studying differentiation and 
patterning in developing embryos.  Previous studies have shown that the basic morphogenetic 
rules governing limb development are the same among all tetrapods. This was underscored by 
demonstrating that grafted pieces of mammalian or reptilian limbs were able to direct limb 
formation in chickens (Fallon and Crosby 1977; Sessions et al. 1989; Hinchliffe 1991).  It was 
also shown that mesodermal cells are critical for limb development in all tetrapods by 
transplanting groups of limb mesodermal cells to different locations along the body axis resulting 
in limb formation at the corresponding areas (Hertwig 1925).  
Limb Bud Initiation and Elongation 
 Vertebrate limb bud initiation commences with the allocation of specialized embryonic 
cells from the lateral plate mesoderm (LPM) into limb fields.  The positioning and induction of 
limb fields along the embryonic axis have been characterized by differential Hox gene 
expression in the LPM: most importantly Hox b6, Hox c8, and Hox b5 (Oliver et al. 1990; 
Rancourt et al. 1995; Nelson et al. 1996). A study involving mutant mice with disrupted Hox b5 
gene resulted in slightly displaced shoulder girdles along the embryonic axis (Rancourt et al. 
1995).  Specific combinations of several Hox gene expressions in the LPM and the embryonic 
trunk also determine the extent of limb outgrowth and the type of limb that develops (Cohn et al. 
1997).  Interestingly, it was shown that variations in Hox expression patterns in the LPM and the 
paraxial mesoderm are responsible for the absence of forelimbs in snakes (Cohn and Tickle 
1999).   
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The initial limb bud consists of mesenchymal cells encased within an epithelial cell layer 
(Searls and  Janners 1971).  Along with Hox genes, limb induction also appears to be critically 
dependent on other factors.  Retinoic Acid (RA), which possibly originates in Hensen’s Node, 
appears to be crucial for initial limb bud differentiation as it facilitates regulation of Hox gene 
expression in the LPM during formation of limb fields  (Hogan et al. 1992, Marshall et al. 1996).  
In a study where RA activity was blocked in the prospective limb areas in stage 12-18 chick 
embryos using the drug disulphiram, limb growth failed to occur (Stratford et al. 1996, 
Hamburger and Hamilton 1951).  Growth Differentiation Factor 11 (GDF11) plays a vital role in 
limb positioning along the axial skeleton as mice deficient in the GDF11 gene developed 
hindlimbs that were displaced posteriorly along the body axis. This observation was coupled 
with an alteration of Hox gene expression patterns (McPherron et al. 1999) suggesting GDF11 
and RA activity upstream of Hox genes in determining limb positioning and induction 
(Capdevilla and Belmonte 2001).  
Following positional specification of limb fields along the embryonic flank, cells of the 
non-limb areas of the LPM divide at a much slower pace, whereas mesodermal cells of the LPM 
limb fields actively engage in cell proliferation, leading to a visible limb outgrowth or 
primordium (Searls and Janners 1971). In the chick embryo, limb buds are visible at stage 17, or 
embryonic day 3 (e3)  (Hamburger and Hamilton, 1951).  The cells of the LPM that give rise to 
the limb bud actively secrete fibroblast growth factor 10 (FGF10), which mediates signaling 
between the proliferating mesodermal cells and the overlying epithelial layer which is induced to 
form a thickened apical ectodermal ridge (AER). Mice deficient in FGF10 expression showed 
limb bud initiation, but no limb growth.  Further analysis of the primordium showed no 
development of AER or zone of polarizing activity (ZPA) (Ohuchi et al. 1997, Sekine et al. 
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1999, Saunders 1948, Kieny 1960, Saunders and Reuss 1974).  The cells of the AER in turn 
express FGF8, which keeps the underlying mesenchymal cells in a proliferative state allowing 
for limb outgrowth to occur through mitosis. This distal set of mesenchymal cells beneath the 
AER is referred to as the progress zone (PZ) as they allow limb elongation to occur (Mahmood 
et al. 1995, Crossley et al. 1996, Vogel et al. 1996, Ohuchi et al. 1997, Kawakami et al. 2001, 
Harrison 1918, Saunders 1948).   
Classical experiments involving transplantations have shown that limb extension occurs 
along 3 axes: the proximal-distal (shoulder-digit)  (PD), dorsal-ventral (knuckle-palm) (DV), and 
the anterior-posterior (thumb-fifth finger) (AP) axes (Johnson and Tabin 1997, Martin 1998).  
Each axis is associated with different organizing centers within the growing limb bud. The AER 
forming at the distal end of the limb bud facilitates continued limb extension along the PD axis 
(Tickle and Altabef 1999).  John Saunders demonstrated that by removing the AER from the 
chick limb during early developmental stages total limb growth was severely compromised 
(Saunders 1948). Furthermore, it was shown that removing the AER at progressively later stages, 
more distal structures were able to form (Saunders 1948).  The Zone of Polarizing Activity 
(ZPA) located at the posterior end regulates growth along the AP axis (Tickle et al. 1975).  The 
protein sonic hedgehog (Shh), which is steadily expressed and secreted by the mesodermal cells 
of the ZPA, confers polarity to the posterior end (Riddle et al. 1993). The dorsal non-ridge 
ectoderm of the limb is the organizing center responsible for DV polarity, which is primarily 
mediated by Wnt-7a expression (MacCabe et al. 1974). 
Chondrogenesis     
In the developing vertebrate limb, skeletal structures form in a proximal-to-distal 
sequence.  Mesenchymal cells that leave the progress zone early result in proximal structures 
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such as the stylopod (humerus or femur), whereas cells that leave the PZ at progressively later 
stages are destined to form more distal structures such as the zeugopod (radius and ulna or tibia 
and fibula) and eventually the autopod (carpus or tarsus and a variable number of digits) 
(Summerbell et al. 1973).  
   The chondrogenic process commences with the condensation of pre-cartilage 
mesenchymal cells of the growing limb bud that have exited the progress zone and therefore are 
out-of-reach of factors secreted by AER that keep cells in a proliferative state. These condensing 
mesenchymal cells aggregate into compact nodules that differentiate into chondrocytes (Hall and 
Miyake 1996).  The induction and maintenance of these condensations are facilitated by 
expression and secretion of N-cadherin and N-CAM (Oberlender and Tuan 1994), as well as 
other factors, such as versican proteoglycan (Williams et al. 2005). In a study using the mouse 
chondrocytic cell line N1511, increased transcription and protein expression of chondroitin 
sulfate proteoglycan (CSPG) versican, especially V0 and V1 isoforms, was observed on treating 
the cells with chondrogenic stimuli such as parathyroid hormone and dexamethasone (Kamiya 
2006).  Versican is known to interact with other extracellular matrix (ECM) molecules such as 
type I collagen, fibronectin, hyaluronan, tenascin, and link protein via its chondroitin sulfate 
chains during mesenchymal condensation (Yamagata et al. 1986, Maleski and Knudson 1996, 
Matsumoto et al. 2003, Mackie et al. 1987, Aspberg et al. 1997). It was demonstrated in vitro 
that versican discourages mesenchymal cell adhesion to markers in the ECM like collagens and 
fibronectin suggesting versican’s possible involvement in mesenchymal aggregation and 
chondrocyte differentiation (Yamagata et al. 1989).  Not surprisingly, during the onset of 
mesenchymal condensation, fibronectin and type I collagen levels increase when compared to 
loose mesenchyme not undergoing condensation.  On chondrocyte maturation, however, type I 
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collagen gets gradually replaced by type II collagen, while fibronectin levels begin to disappear 
(Dessau et al. 1980).  The mesenchymal condensation process initially gives rise to the cartilage 
anlage, which further undergoes skeletogenesis through the endochondral pathway (Fell 1925, 
Thorogood and Hinchliffe 1975, Jurand 1965).  
Formation of Synovial Joints 
 Synovial joint formation along the embryonic limb begins with the flattening and packing 
of non-chondrogenic mesenchymal cells to form the joint interzone (Archer et al. 2003, Craig et 
al. 1987). Even though pathways that dictate synovial joint positioning along the embryonic limb 
are not fully understood, it has been suggested that joint locations are prespecified within the 
mesenchymal condensations of the early limb bud (Khan et al. 2007, Holder 1977, Pacifici et al. 
2005).  Joint interzones in the developing embryo are comprised of a central intermediate zone 
that is sandwiched between two chondrogenous layers lining the epiphyseal ends of the long 
bone anlagen (Craig et al. 1987, Ito and Kida 2000).  It is believed by some that the articular 
cartilage is derived from the cells of the intermediate zone as the outer layers differentiate into 
chondrocytes and add to the growing anlagen (Archer et al. 1994, Ito and Kida 2000).  It was 
also reported that unlike the mesenchymal cells involved in the formation of long bone cartilage, 
joint interzone cells are interconnected by gap junctions, implying close cooperation between 
interzonal cells and synchronized operation in forming the joints (Archer et al. 2003, Pacifici et 
al. 2005).  
 Synovial joint formation hinges critically on the activity of certain key growth factors, 
transcription factors, and signaling molecules.  Growth differentiation factor-5 (GDF-5) is one of 
several key molecules needed for synovial joint initiation since its expression is detected in the 
early chick and mouse joint interzones and even throughout the early mesenchymal 
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condensations (Storm and Kingsley 1996).  Mutant mice lacking the GDF-5 gene showed joint 
deformities such as brachypodism and defects in overall skeletal growth (Storm et al. 1994, 
Settle et al. 2003).  In addition to GDF-5, other factors such as Wnt-14, -catenin, and 
proteoglycans also appear to play decisive roles in establishing the joint interzone.  The Wnt-14 
isoform is expressed in the presumptive joint, and its overexpression in chick embryo limbs 
drives the ectopic expression of other interzone markers such as GDF-5, Chordin and CD44 
(Hartmann and Tabin 2001). Not surprisingly, it was observed that conditional ablation of the 
Wnt signaling mediator -catenin in mouse embryo limb chondrocytes resulted in absence of 
synovial joints (Guo et al. 2004).  These and other findings have led a number of research groups 
to propose that Wnt-14 solely is sufficient for proper synovial joint formation as it acts as an 
upstream regulator of key joint markers such as GDF-5 and -catenin, and maintains the 
mesenchymal nature of the interzone cells by preventing further differentiation into chondrocytes 
(Hartmann and Tabin 2001, Guo et al. 2004). 
 The smooth functioning of synovial joints during later stages of life strongly hinges on 
the process of embryonic synovial joint cavitation, or the timed partitioning of the interzone 
tissue that connects the two opposing joint-forming skeletal structures together (Pacifici et al. 
2005).  Several preliminary studies argued mechanical movement as the cause of joint cavitation, 
whereas others implicated mechanical movement in maintaining the joint cavity (Murray and 
Selby 1930, Hamburger and Waugh 1940, Fell and Canti 1934).  Recent studies however have 
indicated that cavitation is primarily a result of increased expression of Hyaluronic acid (HA) 
and its cell surface receptor CD44 in the interzone (Craig et al. 1990, Archer et al. 1994, 
Edwards et al. 1994, Pitsillides et al. 1995).  Moreover, the inhibition of HA in the interzone, 
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whose accumulation is believed to discourage tissue integrity, led to the inhibition of cavitation 
(Dowthwaite et al. 1998). 
 A vital component of synovial joints is the articular cartilage that forms the “boundaries” 
of synovial joints. Articular chondrocytes differ from the transient chondrocytes forming the 
long bone anlagen in that the former retain their phenotype throughout the life of the organism, 
tend to be less mitotic, and pack more densely during embryonic joint development (Lufti 1974, 
Howlett, 1979). Articular cartilage persistently imparts functional resilience to the joints and 
resists ossification unlike skeletal cartilage tissue, which undergoes cellular hypertrophy, 
apoptosis and inevitable replacement by osteoblasts (Pacifici et al. 2005, Jurand 1965).  
Furthermore, spatial and temporal expression of markers such as collagens, tenascins, and 
chondroitin sulfate proteoglycans (CSPGs) confer to it tensile strength and elasticity (Hay 1991). 
CSPGs and Versican 
 Proteoglycans, or core proteins covalently linked to glycosaminoglycan (GAG) side 
chains, are highly expressed in developing cartilage and synovial joint matrix.  They interact 
with various molecules in forming and maintaining the joints and cartilage via their GAG side 
chains or terminal domains.  Proteoglycans are especially versatile in forming complexes with 
ECM components, keeping cells attached to the ECM, and maintaining tissue structure and 
integrity (reviewed in Rouslahti 1989).  Chondroitin sulfate proteoglycans (CSPGs) or 
proteoglycans with chondroitin sulfate (CS) GAG chains such as versican play critical roles in 
the skeletal development of limbs and joints, and is the subject of this study.  CSPG Versican has 
been found to be highly expressed in the ECM during chondrogenesis and its spatial and 
temporal distribution pattern is believed to be crucial in limb and synovial joint formation 
(Shepard et al. 2007).  
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Alternate splicing of versican (cspg-2 gene) mRNA leads to the generation of four 
isoforms, all of which consists of globular N-terminal G1 and C-terminal G3 domains 
(Zimmermann and Rouslahti 1989).  The N-terminal G1 domain of versican consists of 
immunoglobulin (IgG)-like motifs followed by two-link protein like motifs. It interacts with 
hyaluronic acid specifically, and this complex is further stabilized by association with link 
protein (LP), which facilitates a loose and highly hydrated extracellular environment (Le Baron 
et al. 1992, Lee et al. 1993, Wight 2002, Yamagata et al. 1993). The C-terminal G3 domain 
interacts with molecules such as fibrilin-1 and tenascin, and consists of a C-type lectin-like 
domain, two epidermal growth factor like repeats, and a complement regulatory domain (Isogai 
et al. 2002, Aspberg et al. 1997, Olin et al. 2001, Shinomura et al. 1993). 
  The unspliced versican isoform (Vo), with a molecular weight of more than one million 
Daltons consists of two chondroitin sulfate (CS α and CS β) attachment sites between the G1 and 
G3 domains (Shinomura et al., 1993).  The other spliced forms of versican are V1, V2 and V3 
isoforms.  The V1 isoform consists of G1, CSß, and G3 domains; whereas the V2 isoform 
consists of G1, CSα, and G3 domains. The V3 isoform contains only the G1 and G3 domains      
(Kamiya et al. 2006).  
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Versican in Synovial Joint development 
 A previous study conducted by our laboratory showed varied versican expression during 
progressive stages of chick limb development. Initially, there was uniform versican expression in 
the whole limb primordium. However, at progressively later stages, versican was more defined in 
the synovial joints, whereas other markers such as aggrecan and collagen II were restricted to 
mature chondrocytes of the skeletal template (Shepard et al 2007).  Another study utilizing 
morpholinos to silence versican expression in the developing chick limb between HH stages 22 
and 37 (e3.5-11) resulted in reduced zeugopod and autopod phenotypes (Shepard et al. 2007). 
This study attempts to extend our understanding of versican’s function in synovial joint and 
articular cartilage morphogenesis by using adenovirally encoded shRNAs to assess impacts of 
versican knockdown during synovial joint development. 
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Materials and Methods 
ShRNA Adenovirus Preparation 
shRNA Design and Cloning 
 Our lab designed five short hairpin RNA (shRNA) templates that target versican mRNA 
at nucleotide positions 36, 320, 768, 10330, and 10456 along with a scrambled negative control 
that is non-specific for any RNA sequence.  A published shRNA sequence targeting versican 
mRNA at position 5334 was also used (Sheng 2006). The NCBI BLAST (Basic Local Alignment 
Search Tool) tool was used to verify that the shRNA sequences did not match any of the other 
RNA sequences in the chick genome.  The pSilencer adeno 1.0-CMV system (Ambion Catalog# 
5790) was used to construct shRNA adenoviral constructs.  The shRNA templates were first 
ligated into the pSilencer shuttle vector containing a CMV promoter using DNA ligase. The 
ligation reactions were then used to transform JM109 (Promega) competent E. coli cells.  
Plasmids containing the shRNA sequences were isolated using QIAprep Spin Miniprep kit 
(Qiagen). The Shuttle Vector clone plasmids were then sequenced using the forward sequencing 
primers provided in the PSilencer kit to verify correct shRNA sequence.  Following sequencing, 
the shRNA plasmids were amplified in large-scale E. coli cultures to obtain a minimum plasmid 
concentration of at least 500ng/l for adenoviral preparation.  
Preparation of Recombinant Adenovirus using pSilencer Adeno 1.0 CMV system 
 For preparation of each recombinant shRNA adenovirus, the corresponding plasmid and 
Lac Z adenoviral backbone from the pSilencer kit was linearized using Pac1 restriction 
endonuclease according to kit instructions.  Calcium phosphate transfection media (Clontech) 
was used to co-transfect the linearized digestion products into low density HEK 293 cells in 
DMEM (Dulbecco Modified Eagle’s Media) cell culture media containing 10% heat inactivated 
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fetal bovine serum (FBS) and 1% penicillin/streptomycin (Gibco).  DNA recombination was 
allowed to occur for about two weeks or until cytopathic effect  (CPE) was confirmed.  This was 
usually detected by the presence of adenoviral foci evidenced by detached cells.  At 
approximately 50% CPE, cells were mechanically detached, lysed using three consecutive 
freeze-thaw cycles, and the supernatant was collected via centrifugation. The supernatant, which 
is expected to contain packaged adenoviruses, was used to infect low density HEK-293 cells in 
60 mm cell culture plates for initial expansion of the recombinant adenoviruses.  After adequate 
cytopathic activity was observed (at least 60% of the cells were detached), the cells were 
removed from the plate and transferred to a 10 mL conical tube.  The cells were lysed, 
centrifuged, and the supernatant was used to infect low-density cells in 75cm
2 
cell culture flasks 
for further expansion of the adenoviruses.  The same lysis procedures were repeated to harvest 
adenoviruses from the large-scale cultures.  
Adenovirus Purification and Titration 
 Following cell lysis and adenovirus harvest, the viruses were purified using the Adeno-X 
Virus Mini Purification Kit (Clontech) according to kit instructions.  A total of 0.4 mL of 
adenovirus was eluted form each preparation, and 80 L of cryopreservative was added to each 
eluate.  
 The adenoviruses were then diluted to concentrations of 10
-4
, 10
-5
, and 10
-6
 in DMEM, 
and used to infect HEK-293 cells at 60% confluency for 48 hours in a 37
o
C cell culture incubator 
with humidified 95% air, 5% CO2. Following incubation, the cells were fixed with ice-cold 4% 
paraformaldehyde in phosphate buffered saline (PBS) for 10 minutes at room temperature, and 
subsequently washed three times with PBS. The cells were then incubated in X-gal staining 
solution (0.02% magnesium chloride, 0.1% potassium ferrocyanide, 0.1% potassium 
 
 
12 
ferricyanide, 0.1% Xgal in PBS) until blue Lac Z postive cells were visible. An inverted 
microscope with a 20X objective lens was used to count the number of lacZ positive cells in 
twelve random fields. The average number of Lac Z cells per field was used to calculate the 
adenoviral titer (in infectious units (IFU) / mL) using instructions provided in the Adeno-X 
Rapid Titer Kit User Manual (Clontech).  Adenoviral aliquots were kept at -70
o
C freezer for 
long-term storage.  
Assessment of versican knockdown using Chick Embryo Fibroblasts and Real-time PCR 
Chick Embryo Fibroblast Cell Cultures 
 Chick embryo fibroblast (CEF) cells were isolated from dermal tissues of a day 10 chick 
embryo in PBS.  The tissues were digested with 0.25% Trypsin/EDTA (Invitrogen) for 10 
minutes at 37
o
C. Following digestion, an equal volume of 1:1 DMEM/F12 media containing 
10% FBS was added to the digested cells to quench Trypsin activity. The cells were centrifuged 
at 1000rpm for 5 minutes, and the media was replaced with fresh culture media containing 2% 
FBS.  The cell density was evaluated using a hematocytometer, and adjusted to 250,000 cells per 
50 µl volume.  
Adenoviral Infection and RNA Extraction  
 Three biological replicate cell cultures, each consisting of 2 million cells, were used for 
each adenovirus being tested. The cells were either infected with the 320-virus (viral titer, 5 x 
10
9 
ifu/mL), 5334-virus (viral titer, 5 x 10
9
ifu/mL) or left untreated as a negative control. The 
320-adenovirus was chosen since it showed the best versican silencing activity in in-vitro 
micromass cultures.  In the viral treated cultures, a MOI (multiplicity of infection) of 100 was 
used when infecting the cells. After infection, the cells were seeded in 35 mm culture plates and 
each plate was flooded with 2 mL of DMEM/F12 media containing 2% FBS and incubated.  The 
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culture media was replaced after 24 hours with fresh media containing 10% FBS.  Total RNA 
was extracted from all the replicates following 48 hours of infection using the RNA aqueous-4 
PCR kit (Ambion). RNA concentrations were measured using an Eppendorf Biophotometer.   
Real Time PCR 
 The Superscript III First Strand Synthesis kit (Invitrogen) was used to reverse transcribe 
350ng of total RNA from each biological replicate. Oligo dT priming was used so that only 
mRNA would be reverse transcribed.   The synthesized cDNA-mRNA hybrid was further treated 
with RNase H to degrade complementary mRNA strands.  The cDNA from each replicate was 
then diluted three-fold in nuclease free water and used for real time PCR. Two sets of primers 
were designed for the PCR reactions: one flanking position 320 (for the 320-virus treated cells F: 
AACGTCAGTCCTTCCATGCT, R: TGAATGGGTTGGAACAGACA), and another flanking 
position 5334 (for the 5334-virus treatment F: CCTTTTGAAAGCAACCCAGA, R: 
TGTGCCAGAAGCCAAAGAAG). The real-time PCR reactions were performed in an Applied 
Biosystems ABI 7300 Real-time PCR machine using RT
2
 Real-Time 
TM
 SYBR Green /Rox PCR 
master mix (SuperArray) according to manufacturer’s instructions.  ß-actin primers (F: 
CACAGATCATGTTTGAGACCTT, R: CATCACAATACCAGTGGTACG) were used to 
amplify endogenous ß- actin as an internal control (De Boever et al. 2008). Threshold cycle data 
was analyzed using MS Excel and the Paffle method was used for relative quantification 
calculations (Pfaffl 2001).  Student-t test was also performed to evaluate statistical significance.   
In-ovo Microinjections 
 Fertilized, viral-free chick eggs (Charles River) were incubated in a 37.5
o
C humidified 
egg incubator until the embryos developed to day 5 (e5) or Hamburger and Hamilton (HH) 
stages 24.5-25.  The eggs were ‘windowed’ and the eggshell and vitellin membranes were 
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carefully removed using tungsten needles. The presumptive elbows of the accessible wings 
(usually the right wing) were injected with 1.5µL of either the control shRNA virus, 320-virus, 
5334-virus, or a 1:1 combination of the 320 and 5334 viruses (0.75µL + 0.75 µL).  The 
uninjected wings served as contra-lateral controls (CLC). The viruses were transported into the 
wings using pulled-glass needles inserted into a Narashige Micromanipulator connected to a 
pneumatic pump (Model 820, WPI). Each microinjection delivered approximately 7.5 x 10
6
 
virions.  Furthermore, to verify that the viral media itself was not influencing the resulting 
phenotype, vehicle injection controls were also performed.   The windowed eggs were sealed 
with clear plastic tape and the eggs were placed back in the incubator until desired 
developmental stages were reached (usually HH stages 33-34 or HH stage 36; e8 or e10).  The 
embryos were then harvested, and preserved using appropriate fixatives.  
Whole Mount ß-galactosidase reactivity 
 The ß-galactosidase staining procedure was adapted from (Kern et al. 2007). Virally 
injected embryos were first fixed in ice cold PBS containing 4% paraformaldehyde for 40 
minutes. The fixation was stopped by removing the paraformaldehyde and rinsing the embryos 
three times with PBS for 5 minutes each rinse. The embryos were then washed in a detergent 
based permeablilizing buffer (.02% sodium deoxycolate, .01% Tergitol–type NP-40 in PBS) 
three times, five minutes each wash, and rocked overnight at 4
o
C in the permeablizing buffer. 
Following extensive permeablization, the embryos were incubated in a ß-galactosidase staining 
buffer containing 0.02% magnesium chloride, 0.1% potassium ferrocyanide, 0.1% potassium 
ferricyanide, and 0.1% X-gal (Invitrogen) or Red Gal (Research Organics) in PBS at 37
o
C in the 
dark until a characteristic blue or red color was apparent at sites of viral infection.  Specimens 
were fixed once more with 4% paraformaldehyde for 15-20 minutes to quench further ß-
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galactosidase reactivity, and washed three times with PBS.  For further storage, the embryos 
were kept in PBS at 4
o
C or embedded in paraffin.  
Whole Mount Alcian Blue/ Alizarin Red Histochemistry 
Histochemical staining procedures were employed to analyze in-vivo effects of versican 
knockdown in the synovial joints of whole mount specimens. Alcian blue/Alizarin red whole-
mount histochemistry was used to detect gross morphological changes in the elbow phenotype.  
The impacts on various molecular markers were detected using immunohistochemistry.  Day 10 
embryos were fixed in 95% ethanol overnight at room temperature, followed by overnight 
staining in 0.2 % alcian blue in acidified ethanol (pH 1).  The embryos were rinsed twice with 
95% ethanol for 1 hour each for removal of excess alcian blue stain.  Following the ethanol 
washes, the embryos were macerated with 2% potassium hydroxide (KOH) until the embryos 
were translucent (usually 3-5 hours; Kuczuk and Scott 1984).  The embryos were then stained 
with 0.01% Alizarin Red and further cleared using serial KOH/glycerol washes (80:20, 60:40, 
40:60, 20:80) approximately 60 minutes each wash.  The embryos were kept in 100% glycerol 
for long-term storage (Kuczuk and Scott, 1984).  
Immunohistochemistry 
 Paraffin sections (7 µm) or cryostat sections (10µm) wide were stained with the 
following primary antibodies:  rabbit anti-chick versican (1:50; Zanin et al. 1999), rabbit anti-
phosphohistone H3 (1:100, Cell Signaling), monoclonal mouse supernatants anti-collagen II, 
mouse anti-chick tenascin, mouse anti-chick CD44, and mouse anti-link protein (Developmental 
Studies Hybridoma Bank, Iowa City, IA) (1:5 dilutions). Biotinylated hyaluronic acid binding 
protein (HABP)  (1:100, Cape Cod) was used to localize extracellular hyaluronic acid.  
Secondary immunoreagents used were FITC-conjugated Strepavidin, fluorescein or rhodamine 
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conjugated goat anti-mouse or –rabbit antibodies (ICN-Cappel).  HABP and strepavidin were 
diluted 1:100 in PBS, whereas all other primary and secondary antibodies ere diluted in PBS 
containing 3%BSA (Bovine Serum Albumin) and 1% NGS (Normal Goat Serum).  Before 
primary antibody incubation, sections were treated with Citrate-based Antigen Unmasking 
solution (Vector Labs) and 1mg/mL Bovine testicular hyaluronidase (Sigma), except for sections 
reserved for HABP or CD44 staining which were treated with .25U/mL Chondroitin ABC lyase 
(Sigma).   Following staining, the sections were post-fixed in 80% and 50% ethanol, and 
reequilibrated in PBS. Sections were mounted with coverslips using 10% PBS-90% glycerol 
containing 100 mg/mL 1,4-diazabicyclo (2,2,2) octane (DABCO) (Sigma) and viewed using an 
Olympus BX-40 microscope equipped with epifluorescence optics. Images were captured using a 
SPOT-RT camera and software (diagnostic Instruments).   
TUNEL Assay 
 The TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labeling) assay 
using the ApopTag Peroxidase In Situ Apoptosis Detection Kit (Chemicon) was used to assay 
apoptotic cells by detecting DNA fragmentation characteristic of programmed cell death.  In this 
procedure, slides containing paraffin sections were first deparaffinized and equilibrated in PBS. 
Sections were then incubated in 20 µg/mL Proteinase K in PBS for 15 minutes at room 
temperature, washed three times with PBS to stop enzyme action, and further incubated in 3% 
hydrogen peroxide in PBS for 5 minutes to quench endogenous peroxidase activity. Thirty-µL of 
kit supplied equilibration buffer was added to each specimen and incubation was allowed for 10 
seconds at room temperature.  The equilibration buffer was then aspirated and 30 µL of working 
strength TdT (Terminal deoxynucleotidyl Transferase) enzyme was immediately added to each 
specimen and incubated at 37
o
C in a humidified chamber for 1 hour. The TdT enzyme reaction 
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was inhibited using a working strength Stop/Wash Buffer provided with the kit. Following three 
serial PBS washes, the specimens were incubated in Anti-Digoxigenin conjugate for 30 minutes 
at room temperature. The specimens were washed with PBS three times and incubated in a 
developing solution containing hydrogen peroxide and 3,3’ Diaminobenzidine (DAB) until 
characteristic brown cells were visible.  Sections were mounted with Permount and viewed using 
light microscopy.  
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Results 
To better understand versican function in synovial joint development and morphogenesis, 
we employed an adenovirally mediated RNA-interference strategy utilizing short hairpin RNAs 
or shRNAs.  ShRNAs facilitate site directed cleavage and degradation of mRNA transcripts by 
activating endogenous RNA-Induced Silencing (RISC) complexes. Quantitative real-time PCR 
assessment of shRNA activity of the adenoviruses on chick embryo fibroblasts (CEF) cell 
cultures resulted in 70% knockdown in versican mRNA levels on treatment with the 320-shRNA 
virus, and 50% knockdown when treated with the 5334-shRNA virus following 48 hours of 
infection when compared to an untreated negative control group (Fig.1). The Student t test was 
performed to ensure that the knockdowns were statistically significant. The following null 
hypothesis was tested: There is no difference in the levels of versican mRNA among the 
untreated and adenovirally treated groups of CEF cells. Statistical significance was set at p<0.05.  
Both experimental groups showed statistically significant knockdown in the levels of versican 
mRNA. Furthermore, combined in ovo injections of the 320 and 5334-shRNA adenoviruses into 
chick elbows led to an average reduction of 65% in versican mRNA levels five days following 
injection when compared with the control adenovirus (Fig. 2). Versican protein knockdown was 
assessed by immunostaining with polyclonal rabbit-anti chick versican antibodies (Zanin et al. 
1999).  Reductions in versican staining in synovial joint interzones and articular chondrocytes 
was visible on paraffin sections of wrists injected independently with 320-shRNA (Fig. 3), or 
elbows injected with 5334-shRNA (Fig. 7 D,E) or combined (320+5334)  shRNA viruses (Fig.6 
G,H).  No versican silencing, however, was noticeable for the control shRNA adenovirus (Fig. 5 
C,D). Figure 3B shows versican protein knockdown in a HH stage 36 (e10) wrist (carpal) joint 
previously injected with 320-shRNA adenovirus. On comparison with the contralateral control 
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(CLC) wrist joint (Fig. 3A), a clear reduction in versican expression is apparent in the distal 
articular surface of the ulna and the central lamina of the carpal interzone in the injected wing.  
Sites of shRNA transfection were detected from the blue staining resulting from the reaction 
between β-galactosidase reporter and X-gal.  
Overall effects on synovial joint morphology of shRNA transfection into HH stage 25 
chick elbows were evaluated at HH stages 36-37 (e10) using Alcian Blue and Alizarin Red 
histochemistry.  We noticed an overall 14% average decrease in joint spacing (the clear space in 
the elbow-joint between the distal humerus and proximal radius and ulna) in elbows injected 
with the combined (320 +5334) shRNA adenovirus when compared against the contralateral 
control (CLC) wings (Fig.4 B,C,D). Elbows independently injected with the 5334 and 320 
shRNA viruses showed 13% and 14% reductions respectively in elbow-joint space when 
compared with corresponding contralateral controls (Fig.4 E,F).  Area measurements of the non-
chondrogenic space between the epiphyseal ends of the humerus, ulna and radius were 
performed using the area measurement tool of Image J software from NIH. Interzone area 
measurements of the injected and CLC wings resulting from all the treatments (shRNA control, 
320 shRNA, 5334 shRNA and combined shRNA adenoviruses) were examined using the 
STATDISK software (Triola, 2005).  Data analysis included calculation of means, standard 
deviations, and p-values for joint interzone areas of injected and uninjected contra-lateral control 
wings. Joint interzone area measurements from different wings could not be assumed to be 
statistically independent, and therefore mandated the use of conventional matched pair analysis 
feature of STATDISK (recommended by Dr. Said E. Said, statistics coordinator at ECU math 
department).  The following null hypothesis was tested: There is no difference in the average 
synovial joint interzone area between the injected wing and the CLC wing. Statistical 
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significance was set at p<0.05. From this analysis, we saw that there was a statistically 
significant decrease in interzone areas for wings injected with all combinations of shRNA 
adenoviruses (Table 2). Wings injected with the negative-control shRNA virus showed no 
difference in interzone areas when compared to their contralateral counterparts. Table 1 shows 
the percentage of phenotypes resulting in reduced joint interzones for injected wings.  More than 
50% of viable embryos from each group of experimental adenovirus treatment, stained with 
Alcian Blue and Alizarin Red, showed a reduction in elbow joint spacing. The effects of versican 
knockdown on other factors involved in synovial joint morphogenesis were also examined. 
Consequences on the expression patterns of key synovial joint markers in relation to 
versican knockdown were investigated using immunohistochemistry. For this purpose, embryos 
harvested at HH stages 34 or 36, following three to five days of infection, were LacZ stained and 
the injected and contralateral wings were either paraffin or cryostat sectioned.  Antibody staining 
of wing sections showed altered expression patterns of key synovial joint markers such as 
collagen II, tenascin, link protein, CD-44 and hyaluronic acid (HA) in the joint interzone for the 
experimental adenoviral treated embryos. The most dramatic alterations in collagen II, tenascin 
and link protein expression were noticed for embryos treated with the combined shRNA 
adenovirus set (Figs. 6,10).  Concurrent with versican knockdown in the articular chondrocytes 
lining the epiphyseal border of the humerus, where extensive adenoviral infection occurred for 
most injections, we noticed a dampening in the levels of collagen II, tenascin, and link protein at 
sites of transfection (Figs 6. A-F,10. A-D).  The distal articular chondrocytes of the CLC 
humerus in Figure 6C shows defined collagen II staining along the border between the distal 
humerus and adjacent central interzone lamina. The adenovirus-injected wing in Fig.6D shows 
reduced collagen II staining at this border. Control adenovirus injection showed no differences in 
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the collagen II staining patterns between the CLC and injected wings along the distal humeral 
articular chondrocytes (Fig. 5 G,H). 
In addition to reduced collagen II expression, versican silencing also led to attenuated 
expressions of tenascin and link protein in the articular cartilage matrix. Panels E and F in figure 
6 show tenascin staining in the CLC and the injected wings respectively five days following 
combined adenovirus treatment.  A clear reduction of tenascin can be seen in the distal humeral 
articular chondrocytes of the injected wing, where most adenoviral infection occurred. For the 
control shRNA treatment, there was no reduction in tenascin staining between the injected and 
CLC wings (Fig. 5 E,F).  Similar effects were also observed for embryos treated independently 
with the 5334-adenovirus (Fig. 7).  
Visible reductions in the expression of hyaluronan and CD44 occurred in the joint 
interzone on treatment with experimental shRNAs.  On treatment with 320-shRNA adenovirus, 
there was a marked decrease in the expression of CD44 (Fig.8) and hyaluronan (Fig.9) in the 
joint interzone, especially along the maturing articular cartilage. Figure 8, B shows significant 
disorganization in the staining pattern of CD44 in the joint interzone when compared with the 
CLC wing. Similar disorganizations in hyaluronan expression are noticed in the interzone at sites 
of transfection (Fig. 9 C,D).  
 Interestingly, no significant difference in the number of cells undergoing apoptosis or 
proliferation at sites of shRNA transfection were noticed in the case of the injected elbows when 
compared with the CLC elbows at HH stage 36.  Several specimens were sampled, and the 
number of cells undergoing proliferation at sites of transfection ranged from 3 to 6. In figure 13, 
at sites of transfection, there is no substantial difference between the injected elbow and 
corresponding areas in CLC elbows in either the 320-shRNA treatment (Fig. 13 A-D), or the 
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control (Fig. 13 E-H) treatment. Similarly, no major difference was observed for programmed 
cell death (Fig. 12).  
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Figure 1. Bar graph representing versican knockdown in chick embryonic fibroblast (CEF) cells 
48 hours following infection with sh-RNA adenoviruses. Real time PCR results demonstrate 
70% mRNA knockdown on infection with the 320-shRNA adenovirus and 50% knockdown with 
5334-shRNA adenovirus. P-values obtained from Student t-test indicate significant reductions in 
versican mRNA levels when compared to the untreated control (unt).  
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Figure 2. Real-time PCR assessment of versican mRNA knockdown in ovo on injection with a 
1:1 combination of 320 and 5334-shRNA adenoviruses.  Elbow joints from two sets of embryos 
were injected with the combined shRNA virus (Combined 1 and 2) and incubated for five days. 
Total RNA was extracted from the elbow joints, reverse transcribed, and quantitatively amplified 
against total RNA obtained from control sets injected with the control shRNA adenovirus.  Data 
shows an average reduction of 65% in versican mRNA levels for the combined injections when 
compared with the control adenovirus. 
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Figure 3. Immunohistochemical staining of paraffin sections through chick wing wrist joint at 
HH st36, 5 days following injection with 320-shRNA adenovirus. Protein-antibody staining 
demonstrates strong versican staining along the articular surface lining the distal ulna (u) and 
central lamina of the CLC wing carpal joint (A). A clear versican knockdown is visible in the 
carpal joint of wing injected with 320-shRNA adenovirus, especially among the articular 
chondrocytes lining the distal border of the ulna (B).  Panels C and D are phase contrast images 
of panels A and B respectively. Panel D shows sites of shRNA transfection indicated by blue ß-
galactosidase staining. Scale bar= 50µm. 
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Figure 4. Whole-mount Alcian Blue/Alizarin Red staining of HH stages 36/37 chick wings, five 
days following injection with shRNA adenoviruses.  A: Control adenovirus injections show no 
difference in synovial joint spacing.  B,C,D,E,F indicate reduced elbow joint spacing on 
injection with combined (320,5334) (B,C,D), 5334 (E), and 320 (F)-shRNA adenoviruses. 
Arrows in each panel indicate injected elbow.  The arrowhead in panel F shows an outline of the 
area measured for synovial joint spacing of all specimens.  The red stain in panel B indicates β-
galactosidase-Red Gal reactivity of the adenovirus indicating sites of shRNA transfection.  
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Figure 5. Immunohistochemical staining of paraffin sections through HH stage 36 chick elbows, 
five days following injection with control shRNA adenovirus.  Panel A is a low magnification 
image of the contralateral control elbow interzone.   Intense β-galactosidase (LacZ) staining 
indicating shRNA transfection can be seen in the synovial joint interzone between the humerus 
and ulna of the injected elbow (marked by arrow in panel B). Five days following injection, there 
was no noticeable decrease in the levels of versican, tenascin or collagen II expression (D,F, and 
H) in the elbow joint of the injected wing when compared to the expression levels of versican, 
tenascin, and collagen II (C,E and G) respectively in the contralateral control wing.  Scale bar 
for panels A,B,C,D,G, and H = 100µm. Scale bar for panels E and F = 50µm 
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Figure 6. Immunohistochemical staining of paraffin sections through HH stage 36 chick elbows, 
five days following injection with the combined (320+5334) shRNA adenovirus.  Panels A and 
B are low magnification images of panels C and D respectively.  Panels D, F, and H indicate 
reductions in the levels of collagen II, tenascin and versican in the injected elbow joint when 
compared to corresponding CLC elbow (C,E,G). Defined collagen II staining can be seen in the 
articular cartilage matrix bordering the distal humerus in CLC wing (indicated by arrowhead) 
(C). Collagen II expression is less intense among the distal humeral articular chondrocytes of the 
injected wing (D). Versican expression is also lower in the joint interzone of the injected wing 
(H), especially among the humeral articular chondrocytes, when compared to the CLC wing (G). 
Arrows indicate areas of reduced marker expression. Panels I and J are phase contrast images of 
panels G and H respectively. The arrow head in panel J shows the sites of shRNA transfection. 
Scale bar for panels C-J = 50µm. Scale bar for panels A and B = 100µm. 
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Figure 7. Immunohistochemical staining of paraffin sections through HH stage 36 elbows, 
5 days following injection with the 5334-shRNA adenovirus.  Panel A is a low magnification 
bright field image showing the sites of shRNA transfection in the injected wing.  Panel C 
shows reduced tenascin expression in the articular cartilage matrix of the distal humerus of 
the injected humero-ulnar joint when compared to the CLC joint (B). This corresponds with 
reduced versican expression seen in the articular cartilage of the injected wing (E) when 
compared with that of the CLC wing (D). Panel A in addition to panel E further shows that 
versican silencing has occurred at the sites of sh-RNA transfection.  Panels H and I are 
higher magnifications of the boxed areas of panels F and G respectively. Panel I shows 
reduced collagen II expression among the articular chondrocytes of the injected wing.  Very 
defined collagen II staining can be seen along the articular surface of the distal humerus in 
panel H, especially in the transition between the distal humerus and the adjacent interzone 
lamina.   Scale bar for panels A-G= 100µm, and for panels H-I = 50µm.  
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Figure 8. Immunohistochemical staining of cryostat sections through HH stage 34 elbows, 
3 days following injection with 320-shRNA adenovirus.  Panels A and C show defined 
extracellular CD44 staining in the joint interzone of the CLC wing lining the articular 
cartilage. Panels B and D show less defined and reduced CD 44 extracellular staining in the 
joint interzone of the injected wings. Note that in the injected wing the interzone tissue 
seems loosened and the cells seem to be less densely packed based on the fluorescence and 
phase contrast images.  Panels C and D are higher magnification images of panels A and B.  
Panels E and F are phase contrast images of panels C and D respectively. Arrowhead in 
panel F indicates area of reduced cell densities at sites of sh-RNA transfection indicated by 
the ß-galactosidase staining.  Scale bar for panels A and B = 100µm and for panels C-F = 
50µm 
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Figure 9. Immunohistochemical staining of cryostat sections through HH stage 34 elbows, 
3 days following injection with 320 sh-RNA adenovirus. Panels C and D are higher 
magnification images of the boxed areas in panels A and B respectively, which represents 
the joint interzone space between the humerus (h) and ulna (u) for the injected (panels A, 
C, E and G) wing and the CLC wing  (panels B, D and F).  Robust HA staining is seen in the 
humero-ulnar joint interzone in panel D whereas almost no specific extracellular HA 
staining is apparent in the humero-ulnar joint of the injected wing at sites of sh-RNA 
transfection (panels E and G).  Panel G is a bright field image of panel E.  Scale bar for 
panels A and B = 100µm and for panels C-G = 25µm.  
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Figure 10. Immunohistochemical staining of paraffin sections through HH stage 36 elbows, 
5 days following injection with the combined (320+5334) sh-RNA adenovirus.  Panels C 
and D are low magnification images of the boxed areas in panels A and B respectively. 
Panel D shows a reduction in link protein expression in the injected wing at the articular 
surface of the distal humerus (indicated by arrowhead), where most transfection occurred 
(Panels F and G). Panels F and G are phase contrast and bright field images of panel D 
showing the sites of transfection.  The red color in the phase and bright field images 
indicate ß-galactosidase reactivity.  Panel E is a phase contrast image of panel A.  Scale 
bar=100µm (A,B) and 50µm (C-G).  
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Figure 11. Immunohistochemical staining of paraffin sections through HH stage 36 elbows, 
5 days following injection with control sh-RNA adenovirus.  Panels C and D are high 
magnification images of the boxed areas in panels A and B respectively. Note that there is 
no difference in the level of link protein expression in the distal humeral articular 
chondrocytes (arrow head) between the injected elbow and the ClC elbow.  Panel F is a 
phase contrast image of panel D showing the sites of sh-RNA transfection. Scale bar= 
100µm (A,B); 25µm (C-F).   
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Figure 12.  TUNEL Assay apoptosis staining of paraffin sections through HH stage 36 
elbows, 5 days following injection with control-shRNA adenovirus (A) and combined 
shRNA adenovirus(B).  Panel C shows the contralateral contol counterpart for B.  The boxes 
in the panels enclose areas of sh-RNA transfection that was used to count the number of 
apoptotic cells (stained dark brown).    The boxed area in panel B contained about 9 
apoptotic cells, whereas the boxed area in panel A contained 11 apoptotic cells. No major 
difference was seen in the number of apoptotic cells between the control sh-RNA 
transfected wing and combined sh-RNA transfected wing. Scale bar= 100µm for all panels.  
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Figure 13. Phosphohistone antibody staining of paraffin sections through HH stage 36 
elbows, 5 days following injection with 320 (A-D) and control sh-RNA adenoviruses (E-H).  
Boxed area in panel B indicates almost the same number of histone positive cells as in the 
boxed area in the CLC wing (A).  The difference in the number of histone-positive cells 
between the injected and CLC wings is also not apparent in the embryo injected with the 
control sh-RNA adenovirus.  There seems to be almost the same number of histone positive 
cells in both the injected joint interzone (F) as well as the CLC interzone (E).  Panels G and 
H are phase contrast and bright field images respectively of the CLC wing and the injected 
wing. Panel H shows thorough transfection of the control sh-RNA in the humero-ulnar 
interzone.  Scale bar= 50µm (C). Scale bar for all other panels = 100µm.   
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Table 1. Elbow-joint phenotypes resulting from morphometric analysis of Alcian 
Blue/Alizarin Red stained whole embryos (HH 36-37) injected with control-shRNA, 320-
shRNA, 5334-shRNA and combined (320+5334 shRNAs) at HH24-25. 
 
Adenovirus         Number of Embryos    Embryos with         Percentage   
Injected (n)     Reduced, Interzone                 with phenotype 
                 Areas      
 
 
control-shRNA 6    0    0%  
 
320-shRNA  7    4    57% 
 
5334-shRNA  7    4    57% 
 
320+5334 shRNA 9    5    55% 
 
 
 
 
 
Table 2. Estimated interzone areas in square-millimeters (mm2) at HH 36-37. Mean 
matched-pair analysis was performed to confirm whether differences between average 
interzone areas of the injected versus CLC wings were statistically significant;. Pvalues < 
0.05 was deemed to be significant.  
 
Adenovirus (shRNA)      CLC    Injected             P-value 
 
 
control-shRNA  0.120±0.03               0.120±0.04    NS 
 
 
320-shRNA   0.124±0.03  0.107±0.02  0.03 
 
 
5334-shRNA   0.121±0.02     0.105±0.02  0.041 
 
 
320+5334   0.113±0.02  0.097±0.03  0.02 
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Discussion 
 
  Synovial joint formation is a complex yet increasingly better understood process. Proper 
joint morphogenesis critically hinges on a series of physical and molecular processes that involve 
the flattening of joint interzone cells followed by joint cavitation, which is known to be 
facilitated by the extracellular accumulation of the glycosaminoglycan hyaluronan (HA) in joint 
interzone tissue (Pitsillides et al. 1995, Craig et al. 1990).   A study utilizing chick embryo wings 
recently demonstrated that the hyalectin proteoglycan versican is continuously expressed in the 
joint interzone during early stages of joint morphogenesis.  Interestingly, at progressively later 
stages (HH stage 41 and onward) it was shown that versican activity tends to decline in the joint 
epiphysis, but is persistent among the articular chondroctyes lining the joint interzone (Shepard 
et al. 2007).  
 The intent of this study was to better understand matrix versican’s functions during 
synovial joint establishment in vivo.  We approached this question by attempting to analyze the 
morphologic and molecular consequences of ectopically silencing versican protein levels in the 
synovial joint during early stages of chick elbow joint morphogenesis (HH stage 25) and then 
assessing the effects at progressively later stages (HH stages 34 and 36). We hypothesized that 
knocking down versican would lead to a distortion of synovial joint morphology brought about 
by alterations in the expression patterns of other key synovial joint markers.  To test our 
hypothesis, we used adenovirally-encoded shRNAs previously prepared in our laboratory and in-
ovo microinjection techniques. Alcian Blue/Alizarin Red staining of HH stage 36-embryo wings 
resulted in overall 13-14% reductions in the area of the nonchondrogenous space between 
opposing epiphyseal ends in the shRNA-treated elbows when compared with corresponding 
contralateral controls.  In addition to this diminished elbow spacing, we noticed reduced 
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expression and disorganized distributions of other synovial joint and articular cartilage markers 
including collagen II, tenascin, CD44, HA, and link protein at sites of shRNA transfection.   
 Interestingly, a very recent study utilizing a conditional versican knockout mouse model 
reported a ‘tilting’ of the joints in the digits of the hindlimb autopod.  This ‘tilting’ phenotype 
was ascribed to close packing of mesenchymal cells at the joint interzone, in addition to 
disruptions of chondrocyte columns in the digits.  In the mutant mouse strain, the authors 
observed hypertrophy of chondrocytes, and slight delays in chondrocyte differentiation in the 
digits when compared with hindlimb autopod of control mice fully expressing versican. This 
joint-tilting phenotype and delays in chondrogenesis were further attributed to disruptions in 
versican’s localization of TGFß extracellularly at the sites of impact.  Interestingly, in their 
study, the authors did not notice any phenotypic difference in the more proximal elbow or knee 
joints.  The authors believe that this ‘tilting’ phenotype was only observed in the hindlimb 
autopod, since TGF-ß signaling is more prevalent in that area (Choocheep et al. 2010).  
In our study utilizing a knockdown system, we chose to analyze the impacts of transient 
versican silencing on the more proximal elbow joints.  This was done as a precaution, since 
attempting to inject into the autopod could potentially damage the AER and lead to mechanically 
induced skeletal deformities (Saunders 1948).   Five days after injecting presumptive elbows 
with shRNAs targeting versican, we noticed marked reductions in the expression of extracellular 
collagen II among developing articular chondrocytes concomitant with decreased versican levels 
at sites of transfection.  Since collagen II is a well-established marker for chondrocyte maturity 
and differentiation (Linsenmeyer et al, 1973), a decrease in collagen II among the presumptive 
articular region could manifest as delay in establishing articular chondrocyte maturity and 
permanence.  
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 In addition to reductions in collagen II, we also noticed observable decreases in 
expression of link protein among the early articular chondrocytes of the developing joint 
interzone at sites of versican knockdown. Link protein, in addition to collagen II and aggrecan, is 
a major structural feature of maturing cartilage.  Link protein’s interaction with aggrecan and 
hyaluronan to from a stabilized aggrecan-HA-link protein complex to promote chondrocyte 
stability has been previously recorded (Hardingham 1979).   Recent findings interestingly 
indicate that link protein shows greater affinity towards interactions with the G1 domain of 
versican than the G1 domain of aggrecan to form more stabilized versican-HA-link protein 
ternary complexes (Shi et al. 2004).   
Not surprisingly, a previous study utilizing link protein knockout mice reported cartilage 
deficiencies and disorganizations of chondrocyte columns during epiphyseal-growth plate 
development.  This disorganization of the columns was attributed to weakened depositions of 
proteoglycan-aggregates in the extracellular matrix needed for maintaining cartilage integrity. 
The study also reported decreased chondrocyte sizes.  Intriguingly, the authors did not notice any 
differences in cell proliferation resulting from the absence of link protein.  The authors also 
noted a diminishing in aggrecan staining among the chondrocytes, and an unwillingness of pre-
hypertrophic chondrocytes to differentiate to the hypertrophic state (Watanabe and Yamada 
2003). In our examinations of elbow joints impacted by versican knockdown, we did not notice 
any overt signs of chondrocyte hypertrophy in or near the elbow.  From our demonstrations of 
reductions in collagen II and link protein levels concurrent with curtailed versican expression, in 
conjunction with the findings of Watanabe and Yamada, it seems a viable argument that versican 
plays a pivotal role in preserving the chondrocytic characteristics of articular cartilage by 
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facilitating proper link protein functioning and possibly preventing articular chondrocytes from 
decreasing in size.  
 In our study, the expression pattern of glycoprotein tenascin was also visibly reduced in 
response to versican knockdown in the elbow joint interzone, mainly in the presumptive articular 
cartilage matrix lining the epiphyseal ends of the distal humerus. A previous study demonstrated 
that in cartilaginous areas where reductions in tenascin expression occur, those areas become 
particularly vulnerable to chondrocyte maturation and hypertrophy, eventually leading to 
osteogenesis (Pacifici et al. 1993).  From our findings and that of the study just mentioned, it 
seems reasonable to speculate that if versican silencing is allowed to continue in the joint 
interzones, then the articular chondrocytes of those joints may have higher chances of 
hypertrophy and eventual osteogenesis.  
 In addition to the factors discussed previously, hyaluronan (HA) 
and its cell surface receptor CD44 are also known key players in synovial joint morphogenesis.  
Furthermore, a recent publication has shown that versican is involved in regulating HA and 
CD44 activities in extracellular signal transduction pathways (Suwan et al. 2009).  Another study 
using Hyaluronan synthase 2 (Has 2) knockout mice led to hyaluronan deficiencies in the limb. 
Additionally, defective synovial joint cavities were observed, along with defects in chondrocyte 
maturation confirmed by reductions in extracellular aggrecan.  Moreover, the synovial joints of 
older mice showed increased cell packing and the joints were observed to be wider than usual 
(Matsumoto et al. 2009).  Defective joints were also reported in cases where the interaction 
between hyaluronan and CD44 was interrupted using hyaluronan oligisaccharides (Dowthwaite 
et al. 1998).  In our study investigating effects of versican knockdown, we noticed visible 
deficiencies in both CD44 and hyaluronan expression in the elbow joint interzone consistent with 
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versican silencing. This can be a cause for disruptions in interactions between hyaluronan and 
CD44. In our study, we reported reductions in the non-chondrogenic spacing between opposing 
epiphyseal ends comprising the elbow joint. This reduction in space is possibly due to the 
packing of mesenchymal cells of the central lamina. Also in our situation, we did not notice any 
significant difference in the cell proliferation, or apoptosis between shRNA treated and control 
elbows. Thus from our examination of the various factors impacted by versican knockdown in 
the joint interzone, it seems that our reduced joint-space phenotype is due to a collective effect 
resulting from the altered expression of various synovial joint factors impacted by versican 
silencing.
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Appendix C: PhosphoHistone Assay 
Figure C1. Phosphohistone antibody staining of paraffin sections through HH stage 36 
elbows, 5 days following injection with 5334 (A-D) and control sh-RNA adenoviruses (E-
H).  Boxed area in panel B indicates fewer histone positive cells than in the boxed area in 
the CLC wing (A).  This difference in the number of histone-positive cells between the 
injected and CLC wings is not apparent in the embryo injected with the control sh-RNA 
adenovirus.  There seems to be almost the same number of histone positive cells in both 
the injected joint interzone (F) as well as the CLC interzone (E).  Panels G and H are phase 
contrast and bright images respectively of the CLC wing and the injected wing. Panel H 
shows thorough transfection of the control sh-RNA in the humero-ulnar interzone.  Scale 
bar= 50µm (C). Scale bar for all other panels = 100µm.   
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Appendix D: Cell Size Measurements 
Figure D1. Bar Graph representing alterations in the size of joint interzone cells (in square-
micrometers) as a result of matrix vesican knockdown.  A significant (~24%) reduction in 
area was observed for joint interzone cells infected with the experimental shRNAs (320, 
5334, and 320+5334 combined shRNAs) adenoviruses when compared to interzone cells of 
the CLC wing.  No significant difference in interzone cell area was noted for wings injected 
with the control shRNA when compared with the CLC wing.  The slight difference in 
average cell area between the injected and CLC wings is possibly due to precipitates 
forming on cell surface resulting from the reaction between X-gal and ß-galactosidase.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
62 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
